Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Trial Profile

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Completed
Phase of Trial: Phase II/III

Latest Information Update: 03 Jan 2014

At a glance

  • Drugs Bosentan (Primary)
  • Indications Pulmonary hypertension; Sarcoidosis
  • Focus Therapeutic Use
  • Acronyms BOSAPAH
  • Most Recent Events

    • 03 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top